Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nectar Lifesciences Limited
NECLIFECurrent price
35.26 INR
+0.69 INR (+2.00%)
Last closed
35.28 INR
Company
www.neclife.com
ISIN
INE023H01027
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
8 215 710 405 INR
Yield for 12 month
+39.64 %
1Y
3Y
5Y
10Y
15Y
NECLIFE
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India. Address: SCO 38-39, Chandigarh, India, 160009
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 547.98 INRP/E ratio
135.5185Dividend Yield
–Current Year
+16 872 266 373 INR
Last Year
+15 251 115 496 INR
Current Quarter
+3 596 397 513 INR
Last Quarter
+4 417 920 275 INR
Current Year
+3 383 202 974 INR
Last Year
+3 647 293 660 INR
Current Quarter
+825 885 929 INR
Last Quarter
+948 976 306 INR
Key Figures NECLIFE
1 year
3 years
5 years
10 years
EBITDA
1 582 436 792 INR
Operating Margin TTM
PE Ratio
135.5185
Return On Assets TTM
2.64 %
PEG Ratio
–
Return On Equity TTM
0.47 %
Wall Street Target Price
3 547.98 INR
Revenue TTM
16 508 626 637 INR
Book Value
47.72 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-8.9 %
Dividend Yield
–
Gross Profit TTM
3 647 538 890 INR
Earnings per share
0.27 INR
Diluted Eps TTM
0.27 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
62.5 %
Profit Margin
0.37 %
Dividend Analytics NECLIFE
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
5 %Dividend History NECLIFE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
21.09.2020
Forward Annual Dividend Yield
–
Last Split Factor
10:1
Payout Ratio
–
Last Split Date
12.11.2008
Dividend Date
–
Stock Valuation NECLIFE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
135.5185
Forward PE
–
Enterprise Value Revenue
0.871
Price Sales TTM
0.4977
Enterprise Value EBITDA
8.3032
Price Book MRQ
0.7674
Financials NECLIFE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NECLIFE
For 52 weeks
25.02 INR
56.55 INR
50 Day MA
41.11 INR
Shares Short Prior Month
–
200 Day MA
35.47 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart